Consumer Research
Senate Democrats Reintroduce Comprehensive Cannabis Descheduling Bill, Renewing Push for Federal Reform
WASHINGTON, D.C. - The push for comprehensive federal Cannabis reform ...
Village Farms Reports Q1 2026 Financial Results
VANCOUVER – Village Farms International Inc., known for its large-scale ...
Gotham NYC Launches Accelerator for Black-Owned Cannabis Brands
NEW YORK – Gotham NYC, the city's first Cannabis concept store known for blending retail with art, design and culture, has rolled out a new business accelerator aimed at supporting growth-stage Cannabis consumer-product companies owned ...
New York Bills Advance Low-THC Drinks in Liquor Stores
NEW YORK – A fresh legislative push in New York could soon let customers pick up low-dose Cannabis beverages at their neighborhood liquor store, blending two longstanding retail worlds under tight rules. State Senator Jeremy ...
Rubicon Completes First Harvest at New Cascadia Facility in British Columbia
VANCOUVER, BC – Rubicon Organics Inc. has reached a key operational step with the completion of its first harvest at the newly acquired Cascadia facility in Hope, British Columbia. The company announced this milestone the ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
Virginia Medical Cannabis Generated Over $15M in January
RICHMOND – Virginia's medical Cannabis market reaped $15.1 million in sales during January, according to a report published by the Virginia Cannabis Control Authority. The figure, drawn from 126,706 transactions across the state's licensed pharmaceutical ...
New Study: Medical Cannabis Linked to Measurable Sleep Improvements
NEW YORK- A newly published observational study in PLOS Mental Health adds real-world data to the ongoing discussion around Cannabis and sleep therapeutics. Researchers analyzed outcomes from 124 patients enrolled in the UK Medical Cannabis ...
Single DMT Dose Shows Promise in Cutting TRD Symptoms
NEW YORK – A single intravenous dose of the psychedelic compound dimethyltryptamine (DMT), combined with psychological support, produced rapid and sustained reductions in depressive symptoms among adults with moderate-to-severe major depressive disorder, according to results ...
